Analysts rate these ASX growth shares as buys this month

These growth shares could be buys in May…

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Looking for growth shares to buy in May? Well, here's some good news! Listed below are two growth shares that have recently been named as buys with major upside potential.

Here's what you need to know about them:

Man drawing an upward line on a bar graph symbolising a rising share price.

Image source: Getty Images

Allkem Limited (ASX: AKE)

The first ASX growth share to look at is Allkem. It is one of the world's leading lithium miners with a collection of high-quality operations across different geographies and lithium type.

As Allkem is already shipping lithium in large quantities, it is allowing the company to benefit from the sky high lithium prices which are being driven by the clean energy transition and the rapid adoption of electric vehicles. This bodes well for its earnings growth in the coming years, especially with management aiming to increase its production three-fold by 2026.

Morgans is a big fan of Allkem and has an add rating and $16.98 price target on its shares.

Dicker Data Ltd (ASX: DDR)

Another growth share to look at is Dicker Data. It is a leading technology hardware, software, and cloud distributor, which distributes a growing portfolio of products from the world's leading technology vendors from its new state of the art distribution centre.

Dicker Data recently released its first-quarter update and revealed that its strong growth has continued in FY 2022. The company reported a 50.5% increase in revenue to $673.6 million and a 22.7% lift in profit before tax to $23.8 million.

This was driven by a combination of organic growth and a full quarter contribution from the Exeed acquisition.

One leading broker that appears confident this strong form can continue is Morgan Stanley. In response to its first-quarter update, the broker retained its overweight rating and $16.00 price target on its shares.

Motley Fool contributor James Mickleboro has positions in Allkem Limited. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Dicker Data Limited. The Motley Fool Australia has positions in and has recommended Dicker Data Limited. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

a man wearing casual clothes fans a selection of Australian banknotes over his chin with an excited, widemouthed expression on his face.
Growth Shares

3 ASX shares that could double over the next decade (or much sooner)

These shares could be positioned to deliver strong returns in the future. Let's find out why.

Read more »

A golden egg with dividend cash flying out of it
Growth Shares

Forget Easter eggs, these ASX shares could be your best buys this month

These shares could be top buys after the Easter break.

Read more »

Two smiling work colleagues discuss an investment at their office.
Growth Shares

3 amazing ASX growth shares I'd buy and hold for the next decade

These shares could be worth holding tightly to for the long term.

Read more »

Wife and husband with a laptop on a sofa over the moon at good news.
Growth Shares

$5,000 invested in Droneshield shares 4 months ago is already worth…

Investors will be thrilled!

Read more »

Person with a handful of Australian dollar notes, symbolising dividends.
Dividend Investing

1 ASX dividend share and 1 ASX growth stock to buy in April

These ASX shares deliver a one-two punch: income now, growth later.

Read more »

Increasing white bar graph with a rising arrow on an orange background.
Growth Shares

Here's what I consider to be the very best ASX 200 share to buy in April

This business looks heavily undervalued to me.

Read more »

Scared people on a rollercoaster holding on for dear life, indicating a plummeting share price
Growth Shares

3 reasons to buy this red-hot ASX healthcare stock today

Brokers think the biotech share is gearing up for its next big move.

Read more »

Multi-ethnic people looking at a camera in a public place and screaming, shouting, and feeling overjoyed.
Growth Shares

2 ASX stocks that could help turn $10,000 into $1 million

I’d think about adding these ASX shares to your portfolio.

Read more »